Stock Market News & Analysis

stocks
Continuing problems at the ASX
Interim report by financial regulator is a hit to sentiment.
Continuing problems at the ASX
Continuing problems at the ASX
stocks
Top investing lessons from 2025

Top investing lessons from 2025

13 lessons from Morningstar’s James Gruber.
stocks
Chart of the Week: Aussie dividend yields are less attractive than alternatives

Chart of the Week: Aussie dividend yields are less attractive than alternatives

The latest insights from our equity research team.
stocks
2 ASX shares that benefit from sticky inflation

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Our view of Dexus / Scentre deal

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks
Undervalued ASX retailer benefiting from rebound in spending

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks
Undervalued ASX share searches for cost savings

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks
Chart of the Week: Where we see opportunities after year end market sell-off

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.
stocks
Solving the Australian equities conundrum

Solving the Australian equities conundrum

Where to look in a heavily concentrated index.
stocks
Cutting our fair value on ASX share after poor guidance

Cutting our fair value on ASX share after poor guidance

Our view after the shares stand after a 20% drop.
stocks
2 companies poised to capitalize on the rise of GLP-1 drugs

2 companies poised to capitalize on the rise of GLP-1 drugs

Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
stocks
Does this bank have what it takes to compete with the big 4?

Does this bank have what it takes to compete with the big 4?

Organic growth and a recent acquisition were the focus of their investor day.
stocks
This ASX share is shrinking to greatness

This ASX share is shrinking to greatness

A defensive opportunity for investors.
stocks
Looking for growth outside the ASX100

Looking for growth outside the ASX100

Small caps have outperformed blue chips this year. Here’s some opportunities outside the ASX100.
stocks
Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Our view on the blockbuster merger.
stocks
The trillion-dollar club: Are these mega-sized stocks still buys?

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
of 251
Viewing 1 to 16 of 4003